The launch of the the medication vial marks a significant breakthrough in the approach to body management . This novel therapy combines two distinct mechanisms – activation of the GLP-1 receptor and blocking of the DPP-4 enzyme – providing a distinctive strategy for managing weight concerns. Early patient data demonstrate encouraging efficacy i